...
首页> 外文期刊>Microbiologia Medica >Antimicrobial susceptibility of enterococci from Italian patients with infective endocarditis
【24h】

Antimicrobial susceptibility of enterococci from Italian patients with infective endocarditis

机译:意大利感染性心内膜炎患者肠球菌的药敏性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The epidemiological and clinical study “Studio Endocarditi Italiane” (SEI) evaluated 947 cases of infective endocarditis in 2004-2008. Enterococcal aethiology was described in 11% cases.The aim of our study was to evacuate the in vitro activity of twelve antibiotics alone and in association against 20 strains (15 E. faecalis, 5 E. faecium). Results show the in vitro activity of tigecyicline, daptomicine and linezolid. Synergism is appreciated for ceftriaxone-fosfomycin (FICindex50=0.34, FICindex90=0.56) against E. faecalis and for imipenem-fosfomycin against E. faecium.The majority of the tested strains show addition using ampicillin-ceftriaxone (FICindex50=0.85, FICindex90=1.01) and moxifloxacin- tigecycline (FICindex50=0.77, FICindex90=1.96).
机译:流行病学和临床研究“ Studio Endocarditi Italiane”(SEI)在2004-2008年评估了947例感染性心内膜炎病例。在11%的病例中描述了肠球菌病学。我们的研究目的是撤消12种抗生素的体外活性,并与20种菌株(15种屎肠球菌,5种屎肠球菌)相关联。结果显示了替西西林,达托米星和利奈唑胺的体外活性。头孢曲松-磷霉素(FICindex50 = 0.34,FICindex90 = 0.56)对屎肠球菌和亚胺培南-磷霉素对屎肠球菌具有协同作用。大多数测试菌株显示使用氨苄青霉素-头孢曲松(FICindex50 = 0.85,FICindex90 = 1.01) )和莫西沙星-tigecycline(FICindex50 = 0.77,FICindex90 = 1.96)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号